The 8 analysts offering 12-month price forecasts for Aptose Biosciences Inc have a median target of 10.00, with a high estimate of 13.00 and a low estimate of 8.00. The median estimate represents a +127.27% increase from the last price of 4.40.
The current consensus among 8 polled investment analysts is to Buy stock in Aptose Biosciences Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.17
Reporting Date Mar 30
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.